VOLUNTARY ANNOUNCEMENT GFH375/VS-7375 (Oral KRAS G12D Inhibitor) Achieves Positive Progress across Multiple Clinical Studies in China and Abroad, with Promising Efficacy in Various RAS-mutant Solid Tumors
02595 GenFleet Therapeutics (Shanghai) Inc.GENFLEET-BHong Kong Stock Exchange (H-share)
8 posts
GenFleet Therapeutics (Shanghai) Inc. (02595) at a glance
Prices are from Yahoo! Finance and may be delayed. Always check the latest price before trading.
GenFleet Therapeutics (Shanghai) Inc. (02595) Stock Price History
GenFleet Therapeutics (Shanghai) Inc. closed at HK$29.50 on Oct 22, 2026, +3.7% over 1 month, +11.2% over 1 year.
If you had invested HK$10,000 1 month ago, it would be worth HK$10,365 today (+3.7%).Price change only; dividends and fees are not included.
Over the same period the Hang Seng Index moved −8.6%, while this stock moved +3.7%.
Last 10 Trading Days
| Date | Close | Change | % Change |
|---|---|---|---|
| Oct 22 (Thu) | HK$29.50 | −1.30 | −4.22% |
| Oct 21 (Wed) | HK$30.80 | +1.10 | +3.70% |
| Oct 20 (Tue) | HK$29.70 | +1.84 | +6.60% |
| Oct 16 (Fri) | HK$27.86 | +0.68 | +2.50% |
| Oct 15 (Thu) | HK$27.18 | +0.84 | +3.19% |
| Oct 14 (Wed) | HK$26.34 | −0.66 | −2.44% |
| Oct 13 (Tue) | HK$27.00 | −0.60 | −2.17% |
| Oct 12 (Mon) | HK$27.60 | −1.00 | −3.50% |
| Oct 9 (Fri) | HK$28.60 | +0.44 | +1.56% |
| Oct 8 (Thu) | HK$28.16 | −3.90 | −12.16% |
If you had invested HK$10,000 3 months ago, it would be worth HK$8,021 today (−19.8%).Price change only; dividends and fees are not included.
Over the same period the Hang Seng Index moved −7.9%, while this stock moved −19.8%.
Last 10 Trading Days
| Date | Close | Change | % Change |
|---|---|---|---|
| Oct 22 (Thu) | HK$29.50 | −1.30 | −4.22% |
| Oct 21 (Wed) | HK$30.80 | +1.10 | +3.70% |
| Oct 20 (Tue) | HK$29.70 | +1.84 | +6.60% |
| Oct 16 (Fri) | HK$27.86 | +0.68 | +2.50% |
| Oct 15 (Thu) | HK$27.18 | +0.84 | +3.19% |
| Oct 14 (Wed) | HK$26.34 | −0.66 | −2.44% |
| Oct 13 (Tue) | HK$27.00 | −0.60 | −2.17% |
| Oct 12 (Mon) | HK$27.60 | −1.00 | −3.50% |
| Oct 9 (Fri) | HK$28.60 | +0.44 | +1.56% |
| Oct 8 (Thu) | HK$28.16 | −3.90 | −12.16% |
If you had invested HK$10,000 6 months ago, it would be worth HK$6,330 today (−36.7%).Price change only; dividends and fees are not included.
Over the same period the Hang Seng Index moved −12.3%, while this stock moved −36.7%.
Monthly Closes
| Month | Month-End Close | Monthly % |
|---|---|---|
| Oct 2026 | HK$29.50 | −10.6% |
| Sep 2026 | HK$33.00 | +7.1% |
| Aug 2026 | HK$30.80 | +11.0% |
| Jul 2026 | HK$27.74 | −5.8% |
| Jun 2026 | HK$29.44 | −13.7% |
| May 2026 | HK$34.12 | −20.9% |
| Apr 2026 | HK$43.14 | +29.1% |
If you had invested HK$10,000 1 year ago, it would be worth HK$11,124 today (+11.2%).Price change only; dividends and fees are not included.
Over the same period the Hang Seng Index moved −11.0%, while this stock moved +11.2%.
Monthly Closes
| Month | Month-End Close | Monthly % |
|---|---|---|
| Oct 2026 | HK$29.50 | −10.6% |
| Sep 2026 | HK$33.00 | +7.1% |
| Aug 2026 | HK$30.80 | +11.0% |
| Jul 2026 | HK$27.74 | −5.8% |
| Jun 2026 | HK$29.44 | −13.7% |
| May 2026 | HK$34.12 | −20.9% |
| Apr 2026 | HK$43.14 | +29.1% |
| Mar 2026 | HK$33.42 | +22.0% |
| Feb 2026 | HK$27.40 | −10.7% |
| Jan 2026 | HK$30.70 | +28.9% |
| Dec 2025 | HK$23.82 | −16.9% |
| Nov 2025 | HK$28.66 | +4.9% |
| Oct 2025 | HK$27.32 | ― |
If you had invested HK$10,000 3 years ago, it would be worth HK$7,007 today (−29.9%).Price change only; dividends and fees are not included.
Over the same period the Hang Seng Index moved −13.6%, while this stock moved −29.9%.
Yearly Closes
| Year | Year-End Close | Yearly % |
|---|---|---|
| 2026 (YTD) | HK$29.50 | +23.8% |
| 2025 | HK$23.82 | ― |
Daily, weekly and monthly closes (Yahoo! Finance, split-adjusted, dividends excluded). "All" covers the range Yahoo provides (from Sep 2025). Please check the latest prices before trading.
Posts
This board is shared with the Japanese and Chinese versions. Feel free to write in English, Chinese or Japanese.
VOLUNTARY ANNOUNCEMENT GFH375/VS-7375 (Oral KRAS G12D Inhibitor) Achieves Positive Progress across Multiple Clinical Studies in China and Abroad, with Promising Efficacy in Various RAS-mutant Solid Tumors
LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS
Delete
RESIGNATION OF NON-EXECUTIVE DIRECTOR
Delete
VOLUNTARY ANNOUNCEMENT Disclosure Arrangements for Clinical Data from Studies of GFH375 and GFH276
Delete
ANNOUNCEMENT PURSUANT TO RULE 13.10 OF THE LISTING RULES
Delete
VOLUNTARY ANNOUNCEMENT Announcement on the Progress of Share Repurchase
Delete
2026 Interim Report
Delete
VOLUNTARY ANNOUNCEMENT Favorable Phase II Efficacy Data of GFH375 (Oral KRAS G12D Inhibitor) Monotherapy in Pretreated NSCLC Presented in Oral Session at 2026 World Conference on Lung Cancer (WCLC)
Delete
Write on the GenFleet Therapeutics (Shanghai) Inc. board
More Chinese stocks in English
- YIBIN CITY COMMERCIAL BANK CO., LTD02596
- Beijing Xunzhong Communication Technology Co., Ltd.02597
- Lianlian DigiTech Co., Ltd.02598
- ALUMINUM CORPORATION OF CHINA LIMITED02600
- China Pacific Insurance (Group) Co., Ltd.02601
- Onewo Inc.02602
- Xiamen Jihong Co., Ltd02603
- MetaLight Inc.02605
- Shanghai Pharmaceuticals Holding Co.,Ltd.02607
- Sunshine 100 China Holdings Ltd02608
- Bayzed Health Group Inc02609
- Nanshan Aluminium International Holdings Limited02610